HB1072 Summary

• Authorizes the Board of Psychology to grant prescriptive authority to clinical psychologists who complete specialized training in psychopharmacology, pass a national proficiency exam, and practice in counties with populations under 500,000.

• Requires prescribing psychologists to have a post-doctoral master's degree in clinical psychopharmacology with at least 400 hours of supervised clinical experience and collaboration with a primary care physician for all prescriptions.

• Restricts prescribing psychologists from prescribing Schedule I, II, or III controlled substances and narcotic drugs, except stimulants for ADHD treatment, and prohibits prescribing to patients without a primary care provider.

• Mandates prescribing psychologists complete 18 hours of continuing education biennially and comply with Drug Enforcement Administration registration requirements for controlled substances.

• Sunsets the authorization on August 31, 2024, and requires the Board of Psychology to report to the legislature by 2020 on the program's implementation and results.